Andere Sprachen DexCom, Inc.

Aktien

A0D9T1

US2521311074

DXCM

Medizinische Versorgung

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.01.2025			% 5 Tage	% 1. Jan.
84,38 ^USD	-0,54 %		+8,51 %	+8,50 %

17.01.	S&P 500 verzeichnet 2,9 % wöchentlichen Gewinn aufgrund nachlassenden Inflationsdrucks und starker Bankgewinne	MT
16.01.	Aktien fallen, da Märkte Makrodaten und Gewinne abwägen	MT

Andere Sprachen

S&P 500 Logs 2.9% Weekly Gain on Easing Inflationary Pressures, Strong Bank Earnings	17.01.
Equities Fall as Markets Weigh Macro Data, Earnings	16.01.
Equities Fall as Markets Weigh Macro Data, Earnings	16.01.
Banks, bulls and tame inflation	16.01.
Analyst recommendations: Datadog, Estee Lauder, Netflix, Moderna, EasyJet...	16.01.
Insulet Begins Commercial Sales of Omnipod 5 Insulin Delivery System in 5 More Countries	13.01.
DexCom Reports Higher Preliminary Q4, Full-Year 2024 Revenue; Sets 2025 Revenue Guidance	13.01.
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook	13.01.
Dexcom, Inc. Provides Earnings Guidance for the Year 2025	13.01.
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference	07.01.
UPC: No Requirement To Disclose Commercial Information In Request To Amend Claim	07.01.
Auxiliary Requests Refused Due To UPC's Strict Added Matter Requirements	26.12.
Las 10 mejores acciones de Bankinter para ganar invirtiendo en tecnologías de la salud	26.12.
Abbott Agrees to Global Continuous Glucose Monitoring Litigation Settlement with Dexcom	24.12.
Starbucks, Abbott, Dexcom... Les valeurs à suivre aujourd'hui à Wall Street.	24.12.
Violations de brevets: Abbott et Dexcom font la paix	24.12.
Abbott Laboratories, DexCom Settle Patent Disputes Related to Continuous Glucose Monitoring Products	24.12.
DexCom, Abbott Agree to Settlement in Patent Litigation	23.12.
DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM	21.12.
UPC Inventive Step Assessment Begins To Crystallise With Beginning Of Issuance Of Decisions	20.12.
OURA Secures $200 Million in Series D Funding	20.12.
Oura Health Oy announced that it has received $200 million in funding from DexCom, Inc., Fidelity Management & Research Company LLC	19.12.
Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM	18.12.
Dexcom Launches the First Generative AI Platform in Glucose Biosensing	17.12.
Wall Street : stable, mais le Nasdaq bat un nouveau record	03.12.

Werden Sie Mitglied, um Zugang zu mehr Nachrichten zu erhalten.

100% kostenlose Registrierung

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

DexCom, Inc.: Auf Erfolgskurs im Diabetesmanagement

Am 08. März 2024 um 10:42 Uhr